Why the study?
Older adults with dementia are particularly vulnerable to adverse outcomes from anticholinergic use, prompting evaluation of anticholinergic burden and co-prescription with acetylcholinesterase inhibitors.
Population
66 new referrals with dementia attending a Psychiatry of Later Life service
Comparison
ACB scale vs composite list of anticholinergics
Design
Retrospective chart review
Authors
Loading...
Significant anticholinergic burden in dementia may be underestimated by traditional scales; hypothesis-generating for composite lists before practice change.
Patients with dementia attending a specialist service have a significant anticholinergic burden, which may be underestimated by the traditional ACB scale alone.
Vaughan et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: